RPL36AL
Ribosomal protein eL42-like
Also known as: RL36L_HUMAN, RPL36A, RPL36AP42
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q969Q0
- Gene
- RPL36AL
- Ensembl
- ENSG00000165502
- Chromosome
- 14
- Canonical length
- 106 aa
- Protein class
- Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Endoplasmic reticulum,Plasma membrane,Cytosol
OverviewNCBI Gene
Cytoplasmic ribosomes, organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein, which shares sequence similarity with yeast ribosomal protein L44, belongs to the L44E (L36AE) family of ribosomal proteins. This gene and the human gene officially named ribosomal protein L36a (RPL36A) encode nearly identical proteins; however, they are distinct genes. Although the name of this gene has been referred to as ribosomal protein L36a (RPL36A), its official name is ribosomal protein L36a-like (RPL36AL). As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
106 residues, UniProt reviewed canonical sequence.
>Q969Q0|RPL36AL
1 MVNVPKTRRT FCKKCGKHQP HKVTQYKKGK DSLYAQGRRR YDRKQSGYGG QTKPIFRKKA
61 KTTKKIVLRL ECVEPNCRSK RMLAIKRCKH FELGGDKKRK GQVIQFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPL36AL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 690 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 690 nTPM
- ovary: 559 nTPM
- epididymis: 465 nTPM
- blood vessel: 458 nTPM
- skeletal muscle: 418 nTPM
- stomach: 394 nTPM
Single-cell type
- esophageal apical cells: 2,929 nCPM
- epididymal principal cells: 1,541 nCPM
- esophageal suprabasal cells: 1,453 nCPM
- pancreatic acinar cells: 1,411 nCPM
- epididymal efferent duct absorptive cells: 1,338 nCPM
- mast cells: 1,284 nCPM
Immune cell
- total PBMC: 1,508 nTPM
- basophil: 1,315 nTPM
- MAIT T-cell: 1,116 nTPM
- T-reg: 1,100 nTPM
- memory CD4 T-cell: 1,074 nTPM
- memory CD8 T-cell: 1,041 nTPM
Brain region
- medulla oblongata: 114 nTPM
- white matter: 113 nTPM
- hypothalamus: 112 nTPM
- spinal cord: 110 nTPM
- thalamus: 107 nTPM
- basal ganglia: 104 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.68
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 1.14
- DepMap mean gene effect
- -0.69
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RPL36AL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPL36AL as an antibody target. Whether an autoantibody or antibody against RPL36AL could matter depends on whether native RPL36AL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPL36AL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPL36AL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...